Literature DB >> 32514441

Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: A prospective study.

Jimil Shah1, Usha Dutta1, Ashim Das2, Vishal Sharma1, Harshal Mandavdhare1, Pankaj Sharma1, Dimple Kalsi1, Priyanka Popli1, Rakesh Kochhar1.   

Abstract

BACKGROUND: The Mayo endoscopic score (MES) remains the most commonly used index in clinical practice, as well as in various clinical trials. Recently, two validated histological indices (Nancy Index [NI] and Robert Histological Index [RHI]) have been developed for ulcerative colitis (UC). We aim to study the relationship between MES with NI, RHI, and the established Geboes Index (GI) in patients with UC.
METHODS: This was a prospective single-center study. MES was documented from the most involved area. Biopsy was taken from the same area and reported by a single gastrointestinal histopathologist who was blinded to the endoscopic score. Histological activity was reported using GI, NI, and RHI. Statistical analysis was performed using Spearman's correlation coefficient and Cohen's kappa coefficient using SPSS version 23.
RESULTS: Median age of patients with UC (n = 96) was 36 years. Seventeen patients were in endoscopic remission (MES 0/1). Correlation coefficient between MES and GI/NI/RHI was only weak to moderate (rho = 0.381/0.389/0.442, respectively; P < 0.001 for all three correlations). In patients with endoscopic mucosal healing (n = 17), the agreement coefficient between MES and GI/RHI was weak (κ = 0.253/0.336, respectively; P = 0.001 for both agreements). However, there was no significant agreement coefficient between MES and NI (P = 0.573).
CONCLUSION: MES moderately correlated with histological scores. RHI had the best correlation with MES among all histological indices. Endoscopic mucosal healing is not strongly correlated with histological healing. Histological examination should be performed even in patients with mucosal healing to detect ongoing histological activity.
© 2019 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Geboes Index; Mayo endoscopic score; Nancy Index; Robert Histological Index; ulcerative colitis

Year:  2019        PMID: 32514441      PMCID: PMC7273720          DOI: 10.1002/jgh3.12260

Source DB:  PubMed          Journal:  JGH Open        ISSN: 2397-9070


Introduction

Targets of therapy in ulcerative colitis (UC) have witnessed a paradigm shift from only symptomatic improvement to mucosal healing and, recently, even histological healing. Mucosal healing is defined as the absence of friability, erosions, and ulcers in all visualized segments of gut mucosa.1 Mucosal healing is associated with the decreased risk of disease relapse and disease‐related morbidity.2, 3 However, endoscopic inactivity does not always correlate with histological inactivity.4 Ongoing histological activity may be associated with the increased risk of disease relapse, even in patients with endoscopically normal mucosa.5, 6 Moreover, histological inflammation has also been shown to be associated with increased risk of dysplasia in patients with UC.7 So, it is of utmost importance to understand the relationship between commonly used endoscopic and histological indices in patients with UC. The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) has been recently developed and is a partially validated endoscopic score in patients with UC.8, 9 However, the Mayo endoscopic score (MES) remains the most commonly used endoscopic index in routine clinical practice, as well as in various clinical trials.10, 11, 12 Although not validated, the Geboes Index (GI) still remains one of the most widely used histological scores in routine clinical practice.13 The Nancy Index (NI) and Roberts Histological Index (RHI) are recently developed validated indices for histological evaluation in patients with UC.14, 15 Recently, one study has shown good correlation between the UCEIS score and these histological indices (NI [r = 0.84] and RHI [r = 0.86]).16 However, the relationship of MES with these scoring systems has not been evaluated. This study was conducted to find the relationship between MES and histological scores (GI, NI, and RHI) in patients with UC.

Methods

This was a single‐center study performed at a tertiary care institution in North India. It was a prospective study with an inclusion period from August 2016 to December 2017. The study was approved by the Institutional Ethics Committee. Consecutive patients of UC, with varying levels of disease severity, attending our gastroenterology outpatient services were included in the study. Patients underwent sigmoidoscopy or colonoscopy to assess their endoscopic disease activity. The MES was noted by trained fellows working in our department in the most affected area during endoscopic examination. They were educated regarding use of various endoscopic scoring systems before reporting of endoscopic activity (Table 1).17 MES ≤ 1 was considered endoscopic remission (mucosal healing).1 Biopsy was taken from the most affected area during endoscopic examination and was sent for histopathological examination. A single experienced gastrointestinal histopathologist blinded to the endoscopic activity reported the histological activity using the GI, NI, and RHI. The GI consists of six grades of histological activity, with grade < 3 considered histological remission (Table 2).13 The NI consists of three histological parameters including acute inflammatory cells, chronic inflammatory cells, and ulceration, with score ranging from 0 to 9 and grade ranging from 0 to 4 (Table 3). Grade 0 or 1 represents the absence of acute inflammatory cells and histological remission, while grade 4 is suggestive of severe inflammation.15 The RHI consists of four histological parameters: epithelial neutrophils, lamina propria neutrophils, chronic inflammatory cells, and erosions/ulceration (Table 4). The score varies from 0 to 33, with a score ≤ 3 suggestive of histological remission.14
Table 1

Mayo endoscopic scoring system and data of individual scores in our study group17

Endoscopic appearanceMayo endoscopic score
Normal mucosa0
Decreased vascularity, mild friability, erythema1
Absent vascular pattern, marked erythema, severe friability, erosions2
Spontaneous bleeding, ulceration3
Table 2

Geboes Index for histological scoring and data of individual scores in our study group13

GradeDescription
Grade 0Structural (architectural changes)
0.0No abnormality
0.1Mild abnormality
0.2Mild or moderate diffuse or multifocal abnormalities
0.3Severe diffuse or multifocal abnormalities
Grade 1Chronic inflammatory infiltrate
1.0No increase
1.1Mild but unequivocal increase
1.2Moderate increase
1.3Marked increase
Grade 2Lamina propria neutrophils and eosinophils
2AEosinophils
2A.0No increase
2A.1Mild but unequivocal increase
2A.2Moderate increase
2A.3Marked increase
2BNeutrophils
2B.0No increase
2B.1Mild but unequivocal increase
2B.2Moderate increase
2B.3Marked increase
Grade 3Neutrophils in epithelium
3.0None
3.1<5% crypts involved
3.2<50% crypts involved
3.3>50% crypts involved
Grade 4Crypt destruction
4.0None
4.1Probable local excess of neutrophils in part of crypt
4.2Probable marked attenuation
4.3Unequivocal crypt destruction
Grade 5Erosion or ulceration
5.0No erosion, ulceration or granulation tissue
5.1Recovering epithelium + adjacent inflammation
5.2Probable erosion − focally stripped
5.3Unequivocal erosion
5.4Ulcer or granulation tissue
Table 3

Nancy Index for histological scoring and data of individual scores in our study group15

GradeAcute inflammatory cellsChronic inflammatory cellsUlcerations
0None (0 point)None (0 point)None (0 point)
Mild (1 point)
1None (0 point)Moderate or marked increase (3 points)None (0 point)
2Mild (2 points)Moderate or marked increase (3 points)None (0 point)
3Moderate (3 points)Moderate or marked increase (3 points)None (0 point)
Severe (4 points)
4Moderate (3 points)Moderate or marked increase (3 points)Yes ( 2 points)
Severe (4 points)
Table 4

Roberts Histological Index for histological scoring and data of individual scores in our study group14

ComponentsScoring
Epithelial neutrophils0 = None
1 = <5% crypts involved
2 = <50% crypts involved
3 = >50% crypts involved
Lamina propria neutrophils0 = None
1 = Mild but unequivocal increase
2 = Moderate increase
3 = Marked increase
Chronic inflammatory cell infiltrate0 = No increase
1 = Mild but unequivocal increase
2 = Moderate increase
3 = Marked increase
Erosion or ulceration0 = No erosions or ulceration
1 = Recovering epithelium
1 = Probable erosion‐focally stripped
2 = Unequivocal erosion
3 = Ulcer or granulation tissue

Calculation of RHI: RHI = 1 × chronic inflammatory cell infiltrate (4 levels) + 2 × Lamina propria neutrophils (4 levels) + 3 × Epithelial neutrophils (4 levels) + 5 × Erosions or ulceration (4 levels).

Total score: 0–33.

Mayo endoscopic scoring system and data of individual scores in our study group17 Geboes Index for histological scoring and data of individual scores in our study group13 Nancy Index for histological scoring and data of individual scores in our study group15 Roberts Histological Index for histological scoring and data of individual scores in our study group14 Calculation of RHI: RHI = 1 × chronic inflammatory cell infiltrate (4 levels) + 2 × Lamina propria neutrophils (4 levels) + 3 × Epithelial neutrophils (4 levels) + 5 × Erosions or ulceration (4 levels). Total score: 0–33.

Statistical Analysis

All the data were entered in Microsoft Excel format and then exported to SPSS version 23 (Chicago). Spearman correlation was calculated between MES, GI, RHI, and NI. Agreement between endoscopic and histological correlation was calculated by using Cohen's kappa coefficient. A coefficient of zero indicates that no linear relationship exists between two continuous variables, and a correlation coefficient of −1 or +1 indicates a perfect linear relationship. A value between 0 and 0.19 was regarded as very weak, 0.2–0.39 as weak, 0.40–0.59 as moderate, 0.6–0.79 as strong, and 0.8–1.0 as very strong correlation.18

Results

Baseline characteristics

A total of 96 patients of UC were included in the study, with a median age of 36 [interquartile range (IQR 15)] years; 51 (53.12%) patients were male. Mean duration of the disease was 35.65 ± 35.47 months. Among patient with UC, 82 (85.4%) patients had a relapsing, remitting type of disease course, and 14 (14.6%) patients had a continuous disease course. In our study group, 5 (5.2%) patients had proctitis, 57 (59.4%) patients had left‐sided colitis, and 34 (35.4%) had extensive colitis (Table 5).
Table 5

Baseline characteristic of patients with ulcerative colitis (UC)

Baseline characteristicsFrequency (n = 96) (%)
Age (median) (IQR)36 years (IQR 15)
Male51 (53.12%)
Course of disease
Relapsing remitting82 (85.4)
Continuous14 (14.6)
Extent of disease
Proctitis5 (5.2)
Left‐sided colitis57 (59.4)
Extensive colitis34 (35.4)
Extraintestinal manifestation
Arthritis12 (12.5)
Oral Ulcers2 (2.1)
None82 (85.4)
Baseline characteristic of patients with ulcerative colitis (UC)

Correlation between endoscopic activity and histological indices

The correlation coefficient between MES and the GI/NI was weak, with rho = 0.381 (95% CI 0.20–0.57; P < 0.001) and 0.389 (95% CI 0.17–0.55; P < 0.001), respectively. The correlation coefficient between the MES and RHI was moderate with rho = 0.442 (95% CI 0.26–0.63; P < 0.001). The GI showed a strong correlation with the NI (rho = 0.635; 95% CI 0.47–0.81; P < 0.001) and RHI (rho = 0.708; 95% CI 0.59–0.87; P < 0.001). Correlation between the NI and RHI was also very strong, with rho = 0.872 (95% CI 0.75–0.96; P < 0.001) (Fig. 1 and Table 6).
Figure 1

(a) Correlation between Mayo endoscopic score and Roberts Histological Index (RHI) is moderate [r = 0.442 (95% CI 0.26–0.63; P < 0.001)]; (b) Correlation between RHI and Nancy grading is strong [r = 0.872 (95% CI 0.75–0.96; P < 0.001)].

Table 6

Comparison of Mayo endoscopic score with histological indices

Mayo endoscopic scoreRoberts Histological Index Nancy Index Geboes Index
1 (n = 17)8 (0–21)2 (0–4)3 (0–5)
2 (n = 52)16 (0–33)3 (0–4)5 (0–5)
3 (n = 27)21(5–33)4 (2–4)5 (3–5)

Values expressed as median (range).

(a) Correlation between Mayo endoscopic score and Roberts Histological Index (RHI) is moderate [r = 0.442 (95% CI 0.26–0.63; P < 0.001)]; (b) Correlation between RHI and Nancy grading is strong [r = 0.872 (95% CI 0.75–0.96; P < 0.001)]. Comparison of Mayo endoscopic score with histological indices Values expressed as median (range).

Agreement between endoscopic mucosal healing and histological healing

In our study group, 17 patients were in endoscopic remission (MES 0/1). Agreement between endoscopic remission and histological remission was calculated. The agreement coefficient between MES and GI/RHI was weak, with κ = 0.253 and 0.336, respectively (P = 0.001). However, agreement between MES and NI was statistically nonsignificant (κ = 0.053; P = 0.573).

Discussion

Mucosal healing, a recently defined target of therapy in inflammatory bowel disease (IBD), has been associated with a decreased rate of hospitalization, reduced incidence of colorectal carcinoma, and decreased need of surgery.2, 19 Histological healing is still an evolving concept in the management of UC. Few studies have shown that histological healing as a target of therapy is associated with better outcomes, even in patients with mucosal healing.5, 20 Moreover, ongoing histological activity may be associated with increased disease relapse rates in patients with endoscopically normal mucosa.5, 6 A few previous studies have shown conflicting results on the relationship between endoscopic and histological activity due to the use of heterogeneous, nonvalidated endoscopic and histological indices.21, 22, 23 In our study, MES correlates with the GI, RHI, and NI. However, the strength of the correlation was weak with the GI and NI and moderate with the RHI. The RHI is a recently developed, validated histological index. It includes a wide range of histological activity from 0 to 33, which might be the reason for better expression of various stages of histological activity compared to the other two scoring systems and better correlation with endoscopic activity compared to the other two scoring systems. A similar study was conducted by Lemmens et al., where they had evaluated the correlation between MES with that of the GI and the Riley Histological Index in 131 patients with UC. In their study as well, the correlation between MES and the histological index was moderate, with r = 0.482 (P < 0.001).24 Simsek et al. have studied the relationship between the Rachmilewitz Endoscopic Activity Index (EAI) and Harpaz Histopathological Activity Scoring System (HSS) in 109 patients with UC. In that study, they have found poor agreement between endoscopic and histological scoring systems.21 In a study by Kovach et al., the correlation between MES and GI was weak to moderate for different parameters (rho = 0.14–0.48).22 However, a recent study by Irani et al. evaluated the correlation between UCEIS score and the RHI and NI. In their study, a strong correlation between endoscopic and histological indices was found (r = 0.86 and r = 0.84 respectively; P < 0.001).16 UCEIS is a more extensive and validated score, which might be why there is better correlation with histological indices compared to MES. However, other studies have found only a weak to moderate correlation between MES and histological indices similar to our study results. In our study 17 patients were in endoscopic remission. We computed agreement between endoscopic and histological remission. We had used the definition of endoscopic remission (MES ≤ 1) as per standard criteria and use in different studies.1, 10, 12 Endoscopic remission and histological remission by GI and RHI showed weak agreement. However, agreement between MES and NI was statistically nonsignificant. However, in our study, all 17 patients with endoscopic remission had an MES of 1. In a study by Lemmens et al., an MES of 1 showed poor correlation with histological activity, and patients with an MES of 1 had different grades of histological activity. In study by Simsek et al., they had also found poor agreement between endoscopic remission and histological remission.21 In our study, none of the patients had an MES of 0, which might be why there is poor agreement between endoscopic and histological indices. Moreover, this also suggests that an MES of 1 is a poor predictor for histological remission. Our study has few limitations. We have not evaluated interobserver variation in MES reporting, which might be why there is moderate correlation of MES with histological activity. None of the patients were had an MES of 0, which might be the reason for poor agreement between endoscopic and histological remission. Moreover, being a single‐center study, large multicenter studies are needed for the validation of results of this study. To conclude, MES only moderately correlated with histological scores. The RHI had the best correlation with MES among all histological indices. An MES of 1 poorly correlated with histological remission. Histological examination should be performed even in patients with mucosal healing to detect ongoing histological activity. A better validated endoscopic index is needed for defining endoscopic activity and remission.
  24 in total

1.  Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.

Authors:  Margalida Calafat; Triana Lobatón; Alba Hernández-Gallego; Míriam Mañosa; Paola Torres; Fiorella Cañete; Eduard Cabré; Isabel Ojanguren; Eugeni Domènech
Journal:  Dig Liver Dis       Date:  2017-09-08       Impact factor: 4.088

Review 2.  The emerging role of histologic disease activity assessment in ulcerative colitis.

Authors:  Rish K Pai; Vipul Jairath; Niels Vande Casteele; Florian Rieder; Claire E Parker; Gregory Y Lauwers
Journal:  Gastrointest Endosc       Date:  2018-08-22       Impact factor: 9.427

3.  Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis.

Authors:  Bart Lemmens; Ingrid Arijs; Gert Van Assche; Xavier Sagaert; Karel Geboes; Marc Ferrante; Paul Rutgeerts; Séverine Vermeire; Gert De Hertogh
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

4.  Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.

Authors:  William J Sandborn; Chinyu Su; Bruce E Sands; Geert R D'Haens; Séverine Vermeire; Stefan Schreiber; Silvio Danese; Brian G Feagan; Walter Reinisch; Wojciech Niezychowski; Gary Friedman; Nervin Lawendy; Dahong Yu; Deborah Woodworth; Arnab Mukherjee; Haiying Zhang; Paul Healey; Julian Panés
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

5.  Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.

Authors:  J Ignacio Fernández-Blanco; Guillermo Fernández-Díaz; Carlos Cara; María I Vera; David Olivares; Carlos Taxonera
Journal:  Dig Dis Sci       Date:  2018-01-25       Impact factor: 3.199

6.  Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

Authors:  Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert Van Assche; Ilse Hoffman; Kristel Van Steen; Séverine Vermeire; Paul Rutgeerts
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

7.  Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis.

Authors:  Vikram Narang; Ravneet Kaur; Bhavna Garg; Ramit Mahajan; Vandana Midha; Neena Sood; Ajit Sood
Journal:  Intest Res       Date:  2018-01-18

8.  Correlation Between Endoscopic and Histological Activity in Ulcerative Colitis Using Validated Indices.

Authors:  Nazneen R Irani; Lai Mun Wang; Gary S Collins; Satish Keshav; Simon P L Travis
Journal:  J Crohns Colitis       Date:  2018-11-09       Impact factor: 9.071

9.  Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis With Endoscopically Normal Mucosa.

Authors:  Ryo Ozaki; Taku Kobayashi; Shinji Okabayashi; Masaru Nakano; Shojiroh Morinaga; Atsuko Hara; Makoto Ohbu; Kentaro Matsuoka; Takahiko Toyonaga; Eiko Saito; Tadakazu Hisamatsu; Toshifumi Hibi
Journal:  J Crohns Colitis       Date:  2018-11-15       Impact factor: 9.071

10.  The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

Authors:  Simon P L Travis; Dan Schnell; Brian G Feagan; Maria T Abreu; Douglas G Altman; Stephen B Hanauer; Piotr Krzeski; Gary R Lichtenstein; Philippe R Marteau; Jean-Yves Mary; Walter Reinisch; Bruce E Sands; Patrick Schnell; Bruce R Yacyshyn; Jean-Frédéric Colombel; Christian A Bernhardt; William J Sandborn
Journal:  J Crohns Colitis       Date:  2015-05-08       Impact factor: 9.071

View more
  5 in total

1.  Drug-Induced Intersticial Nephritis. Clinical Case.

Authors:  Paulina Tekoriutė; Monika Matuliauskaitė; Laimas Virginijus Jonaitis
Journal:  Acta Med Litu       Date:  2021-08-11

2.  Automated evaluation of colon capsule endoscopic severity of ulcerative colitis using ResNet50.

Authors:  Naoki Higuchi; Hiroto Hiraga; Yoshihiro Sasaki; Noriko Hiraga; Shohei Igarashi; Keisuke Hasui; Kohei Ogasawara; Takato Maeda; Yasuhisa Murai; Tetsuya Tatsuta; Hidezumi Kikuchi; Daisuke Chinda; Tatsuya Mikami; Masashi Matsuzaka; Hirotake Sakuraba; Shinsaku Fukuda
Journal:  PLoS One       Date:  2022-06-10       Impact factor: 3.752

3.  An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.

Authors:  Christopher Ma; Rocio Sedano; Ahmed Almradi; Niels Vande Casteele; Claire E Parker; Leonardo Guizzetti; David F Schaeffer; Robert H Riddell; Reetesh K Pai; Robert Battat; Bruce E Sands; Christophe Rosty; Marla C Dubinsky; Florian Rieder; Noam Harpaz; Maria T Abreu; Robert V Bryant; Gregory Y Lauwers; Richard Kirsch; Mark A Valasek; Eileen Crowley; William J Sandborn; Brian G Feagan; Rish K Pai; Vipul Jairath
Journal:  Gastroenterology       Date:  2021-02-19       Impact factor: 22.682

4.  Investigation of Cytomegalovirus in Intestinal Tissue in a Country With High CMV Seroprevalence.

Authors:  Hande Hazır-Konya; Vildan Avkan-Oğuz; Hale Akpınar; Özgül Sağol; Arzu Sayıner
Journal:  Turk J Gastroenterol       Date:  2021-02       Impact factor: 1.852

5.  Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis.

Authors:  Olga Maria Nardone; Yifat Snir; James Hodson; Rosanna Cannatelli; Nunzia Labarile; Keith Siau; Cesare Hassan; Henit Yanai; Iris Dotan; Subrata Ghosh; Marietta Iacucci
Journal:  Therap Adv Gastroenterol       Date:  2022-04-29       Impact factor: 4.802

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.